Sumitomo Pharma Co., Ltd.
DNPUF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.19B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $5.19 Billion |
|---|---|
| Enterprise Value | $89.21 Billion |
| Earnings per Share | $270.03 |
| Beta | 0.45 |
| Outstanding Shares | 435,626,000 |
Return
| Return on Equity | 27.98% |
|---|---|
| Return on Assets | 13.53% |
| Return on Invested Capital | 18.72% |
Valuation & Multiples
| P/E Ratio | 6.62 |
|---|---|
| PEG | 12.82 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 0.19 |
| Enterprise Value to EBIT | 0.82 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 1.8 |
| Debt to Equity | 0.39 |
Revenue Sources
No data
Last Earnings Call
Report Date
July 31, 2026
EPS Estimate
$0.12
Consensus analyst estimateRevenue Estimate
$696.74 M
Consensus analyst estimateNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
$0.18
Consensus analyst estimateRevenue Estimate
$842.06 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Sumitomo Pharma Co., Ltd.
3,123 employees
CEO: Toru Kimura
Sumitomo Pharma Co., Ltd. is a global company involved in the creation, production, and sale of a variety of products, including human pharmaceuticals, food ingredients and additives, and veterinary medicines. Its operations span across ...